BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33727040)

  • 21. MACC1 mediates chemotherapy sensitivity of 5-FU and cisplatin via regulating MCT1 expression in gastric cancer.
    Wang C; Wen Z; Xie J; Zhao Y; Zhao L; Zhang S; Liu Y; Xue Y; Shi M
    Biochem Biophys Res Commun; 2017 Apr; 485(3):665-671. PubMed ID: 28235486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dichloroacetate attenuates hypoxia-induced resistance to 5-fluorouracil in gastric cancer through the regulation of glucose metabolism.
    Xuan Y; Hur H; Ham IH; Yun J; Lee JY; Shim W; Kim YB; Lee G; Han SU; Cho YK
    Exp Cell Res; 2014 Feb; 321(2):219-30. PubMed ID: 24342832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.
    Li LQ; Pan D; Chen Q; Zhang SW; Xie DY; Zheng XL; Chen H
    Cell Physiol Biochem; 2018; 47(4):1533-1545. PubMed ID: 29940566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
    Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF
    Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The c-MYC-ABCB5 axis plays a pivotal role in 5-fluorouracil resistance in human colon cancer cells.
    Kugimiya N; Nishimoto A; Hosoyama T; Ueno K; Enoki T; Li TS; Hamano K
    J Cell Mol Med; 2015 Jul; 19(7):1569-81. PubMed ID: 25689483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardamonin, a natural chalcone, reduces 5-fluorouracil resistance of gastric cancer cells through targeting Wnt/β-catenin signal pathway.
    Hou G; Yuan X; Li Y; Hou G; Liu X
    Invest New Drugs; 2020 Apr; 38(2):329-339. PubMed ID: 31102118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CISD2 enhances the chemosensitivity of gastric cancer through the enhancement of 5-FU-induced apoptosis and the inhibition of autophagy by AKT/mTOR pathway.
    Sun Y; Jiang Y; Huang J; Chen H; Liao Y; Yang Z
    Cancer Med; 2017 Oct; 6(10):2331-2346. PubMed ID: 28857517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
    Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T
    Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcription Factor AP2ε: A Potential Predictor of Chemoresistance in Patients With Gastric Cancer.
    Sun J; Du N; Li J; Zhou J; Tao G; Sun S; He J
    Technol Cancer Res Treat; 2016 Apr; 15(2):285-95. PubMed ID: 25810491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silence of FAM83H-AS1 promotes chemosensitivity of gastric cancer through Wnt/β-catenin signaling pathway.
    Wang B; Guan G; Zhao D
    Biomed Pharmacother; 2020 May; 125():109961. PubMed ID: 32028241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells.
    Giraud J; Molina-Castro S; Seeneevassen L; Sifré E; Izotte J; Tiffon C; Staedel C; Boeuf H; Fernandez S; Barthelemy P; Megraud F; Lehours P; Dubus P; Varon C
    Int J Cancer; 2020 Apr; 146(8):2255-2267. PubMed ID: 31489619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silencing of XB130 is associated with both the prognosis and chemosensitivity of gastric cancer.
    Shi M; Huang W; Lin L; Zheng D; Zuo Q; Wang L; Wang N; Wu Y; Liao Y; Liao W
    PLoS One; 2012; 7(8):e41660. PubMed ID: 22927913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha 7-nicotinic acetylcholine receptor mediates the sensitivity of gastric cancer cells to 5-fluorouracil.
    Chen WY; Huang CY; Cheng WL; Hung CS; Huang MT; Tai CJ; Liu YN; Chen CL; Chang YJ
    Tumour Biol; 2015 Dec; 36(12):9537-44. PubMed ID: 26136123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The HER4-YAP1 axis promotes trastuzumab resistance in HER2-positive gastric cancer by inducing epithelial and mesenchymal transition.
    Shi J; Li F; Yao X; Mou T; Xu Z; Han Z; Chen S; Li W; Yu J; Qi X; Liu H; Li G
    Oncogene; 2018 May; 37(22):3022-3038. PubMed ID: 29535422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WNT6 is a novel target gene of caveolin-1 promoting chemoresistance to epirubicin in human gastric cancer cells.
    Yuan G; Regel I; Lian F; Friedrich T; Hitkova I; Hofheinz RD; Ströbel P; Langer R; Keller G; Röcken C; Zimmermann W; Schmid RM; Ebert MP; Burgermeister E
    Oncogene; 2013 Jan; 32(3):375-87. PubMed ID: 22370641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of Lin28 Decreases the Chemosensitivity of Gastric Cancer Cells to Oxaliplatin, Paclitaxel, Doxorubicin, and Fluorouracil in Part via microRNA-107.
    Teng R; Hu Y; Zhou J; Seifer B; Chen Y; Shen J; Wang L
    PLoS One; 2015; 10(12):e0143716. PubMed ID: 26636340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells.
    Zheng P; Chen L; Yuan X; Luo Q; Liu Y; Xie G; Ma Y; Shen L
    J Exp Clin Cancer Res; 2017 Apr; 36(1):53. PubMed ID: 28407783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CAP2 promotes gastric cancer metastasis by mediating the interaction between tumor cells and tumor-associated macrophages.
    Zhang G; Gao Z; Guo X; Ma R; Wang X; Zhou P; Li C; Tang Z; Zhao R; Gao P
    J Clin Invest; 2023 Nov; 133(21):. PubMed ID: 37707957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corosolic acid reduces 5‑FU chemoresistance in human gastric cancer cells by activating AMPK.
    Park JB; Lee JS; Lee MS; Cha EY; Kim S; Sul JY
    Mol Med Rep; 2018 Sep; 18(3):2880-2888. PubMed ID: 30015846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Immune-microenvironment Confers Chemoresistance of Colorectal Cancer through Macrophage-Derived IL6.
    Yin Y; Yao S; Hu Y; Feng Y; Li M; Bian Z; Zhang J; Qin Y; Qi X; Zhou L; Fei B; Zou J; Hua D; Huang Z
    Clin Cancer Res; 2017 Dec; 23(23):7375-7387. PubMed ID: 28928161
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.